The filing is a routine insider intent-to-sell notice with no material impact. Monitor for any subsequent Form 4 filings to confirm execution, but no further action warranted.
XNCR drugs
XNCR drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 12 $38.13entry
- T+1 · 4d ago −2.73%α −2.36% · $37.09
- T+2 · todayOpen
- T+5 · in 2d Pending
- T+20 · in 24d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Bart Jan Cornelissen, an officer of Xencor, filed a Form 144 notice to sell 10,100 shares of common stock with an approximate market value of $402,182. The shares were acquired through ESPP purchases and restricted stock vesting in 2024 and 2025. The sale is small relative to the company's $3.0B market cap and appears routine.
Key Facts
- Reporting person: Bart Jan Cornelissen, an officer of Xencor
- Shares to be sold: 10,100 shares of common stock
- Approximate value: $402,182
- Shares acquired via ESPP purchase (884 shares on 12/10/2024) and restricted stock vesting (9,216 shares on 04/09/2025)
- Broker: Fidelity Brokerage Services LLC
- Filing date: 2026-11-12; proposed sale date: 11/11/2026
Financial Impact
Sale of 10,100 shares valued at ~$402K, representing ~0.013% of Xencor's $3.0B market cap
Risk Factors
- Insider sale could be perceived negatively if it signals lack of confidence, but the small size relative to market cap mitigates this risk
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-007947 |
| Document: 0001959173-26-007947-index.html | 0001959173-26-007947 |
| Document: 0001959173-26-007947.txt | 0001959173-26-007947 |
Track record
20 reports on XNCR
4 of 7 bullish or bearish reports moved the stock their way by T+1. Best: +67.24% at T+60 after the May 5, 2026 report. 5 of 7 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $35.40 Now $35.40 +0.00% settles Nov 18
- Nov 13, 20263d ago SC 13G Neutral 3/10 Entry $39.23 Now $35.40 −9.77% settles Nov 17
- Nov 12, 20264d ago Insider Cluster Neutral 4/10 Entry $37.09 to $35.40 Now $35.40 −4.56% ▼ −4.56% −2.65% vs SPY
- Nov 12, 20264d ago 144 Neutral 2/10 Viewing Entry $38.13 to $37.09 Now $35.40 −7.16% ▼ −2.73% −2.36% vs SPY
- Nov 10, 20266d ago 144 Neutral 3/10 Entry $39.97 to $38.13 Now $35.40 −11.43% ▼ −4.60% −4.25% vs SPY
- Nov 6, 202610d ago SC 13G/A Neutral 3/10 Entry $35.75 to $38.59 Now $35.40 −0.98% ▲ +7.94% +5.58% vs SPY
- Nov 4, 202612d ago 8-K Neutral 5/10 Entry $34.05 to $35.75 Now $35.40 +3.96% ▲ +4.99% +4.68% vs SPY
- Oct 30, 202617d ago SC 13G/A Bearish 4/10 Entry $29.82 to $29.66 Now $35.40 −18.71% ▲ +0.54% +0.06% vs SPY
- Oct 27, 202620d ago SC 13G/A Neutral 2/10 Entry $29.99 to $29.21 Now $35.40 +18.04% ▼ −2.60% −2.22% vs SPY
- Oct 26, 202621d ago 8-K Bullish 6/10 Entry $29.18 to $29.99 Now $35.40 +21.32% ▲ +2.78% +2.22% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers